RxDoctor Payments Data

Hannah Asghari, MD

Hematology-Oncology · Lancaster, CANPI 1891114583

Payments from drug & device makers

What this record shows

That places this record below the midpoint for hematology-oncology clinicians in CA, where the typical reported total is $1,839.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 30th percentile of 53 hematology-oncology providers in California.

See all hematology-oncology providers in California

Medicare billing

Part B allowed, 2024
$1,893,316
Medicare patients
489
Services billed
87,713

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IbrancePalbociclib24$362,786
RevlimidLenalidomide13$362,281
ErleadaApalutamide12$168,215
EliquisApixaban27$17,111
Exemestane13$2,212
Letrozole46$937
Anastrozole48$854
Dexamethasone37$354
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$245
Prochlorperazine Maleate15$179
Levothyroxine Sodium19$158
Ondansetron Hcl25$128
Acyclovir18$89
Allopurinol11$71
Prednisone11$23

Paid to pharmacies, not to this prescriber.

Other hematology-oncology in Lancaster

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →